MS

Mohan S. Iyer

GP at SOSV/IndieBio

San Francisco, California

Invests in

  • Min Investment:

    $100,000.00
  • Max Investment:

    $2,000,000.00
  • Target Investment:

    $1,000,000.00

Work Experience

2021

  • General Partner

    2021

    Serving genius entrepreneurs to realize their vision of a better world by creating, scaling, and exiting meaningful new companies in human and planetary health

2017 - 2021

  • COO

    2017 - 2021

    Revolutionizing metabolic health | The first medical probiotic for people with type 2 diabetes to manage A1C, naturally.

2012 - 2017

  • Chief Business Officer

    2012 - 2017

    The first venture-backed microbiome company | The most important genome in your body may not be your own.

  • CFO

    2011 - 2011

  • Chief Business Officer

    2009 - 2011

    Next-gen diagnostics from cutting-edge proteomics and metabolomics | The first commercial test to predict those at highest risk of converting to type 2 diabetes.

2006 - 2009

  • Managing Director, Merchant Banking

    2006 - 2009

    Strategic transactions (M&A and partnering) and selected financings for life science companies.

1997 - 2005

  • EVP, Corporate and Business Development

    1997 - 2005

    JV between GSK and Incyte | First mover in genomics-based diagnostics | The first and only diagnostic test for vulnerable plaque/risk of heart attack independent of cholesterol.

  • Senior Healthcare Consultant

    1995 - 1997

    Highly-focused and intensely-credible management consulting firm serving leading companies in pharma, biotech, diagnostics, and medical devices | Integrated into IBM Healthcare.

1986 - 1993

  • Senior Process Engineer

    1986 - 1993

    At the ground floor where it all began | Biochemical engineer helping to scale cGMP production of first 3 recombinant protein therapeutics that launched the biotechnology industry.